Table 5.
CE, STS, phase-locking, and oscillation indices and power spectral peaks (of sLFP) across different networks and neuromodulatory states
| Control | nAChR | mAChR | nAChR + mAChR | |
|---|---|---|---|---|
| Glomerular model | ||||
| CE | 2.58 | 7.51 | ||
| STS | 2.70 | 3.51 | ||
| Phase-lockinga | 0.38 | 0.45 | ||
| Oscillationa | 0.27 | 0.40 | ||
| Spectrum peak | 0.29 | 0.53 | ||
| Full model with EPL | ||||
| CE | 2.55 | 12.13 | 2.78 | 16.04 |
| STS | 5.20 | 4.94 | 7.50 | 8.30 |
| Phase-lockinga | 0.62 | 0.60 | 0.73 | 0.74 |
| Oscillationa | 0.65 | 0.71 | 0.75 | 0.75 |
| Spectrum peak | 0.90 | 0.76 | 1.65 | 1.66 |
a The phase-locking and oscillation indices are bounded between 0 and 1.